A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008553/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe
Atopic Dermatitis
提供机构：
Vivli
创建时间：
2022-10-11
